Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)

التفاصيل البيبلوغرافية
العنوان: Testing LOXO-101 as Potentially Targeted Treatment in Cancers With NTRK Genetic Changes (MATCH - Subprotocol Z1E)
المصدر: MATCH Treatment Subprotocol Z1E: Larotrectinib (LOXO-101) in Patients With Tumors With NTRK Fusions
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT06390852Test
قاعدة البيانات: ClinicalTrials.gov